Amesite Inc. expects sales growth due to high demand for NurseMagic™ in healthcare industry.

From GlobeNewswire: 2025-04-04 18:17:00

Amesite Inc., a U.S.-owned AI developer, remains unaffected by recent U.S. tariffs due to its fully remote, U.S.-based workforce and cloud-native infrastructure. The company’s flagship product, NurseMagic™, reduces charting time by 95% and is in high demand in the home health industry. With a focus on efficiency, accuracy, and scalability, Amesite is onboarding larger organizations and expanding its user base. The platform meets HIPAA regulations and offers seamless integration into healthcare workflows, serving users across 50 states and 21 countries. Amesite’s operations are insulated from tariff impacts, positioning the company for continued growth and success.



Read more at GlobeNewswire: AMST) Anticipates Sales Growth Amid